Signal active
Investment Firm
Overview
Ulysses is the successor firm to Odyssey Partners, LP, the pioneering hedge fund. Odyssey was an innovator in the development of the alternative investment market and made some of the earliest private equity investments almost 40 years ago when they were known as ‘bootstrap’ investments. This tradition of investment innovation continues within the Ulysses private equity group, which is one of our three principal areas of investment focus along with the public market and real estate investments.
Highlights
1982
Impact Investing
51-100
4
0
2
Early Stage Venture, Late Stage Venture
Hedge Fund, Private Equity Firm
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Ulysses Management, established in 1982 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Software, SaaS, Enterprise, Financial Services, Venture Capital, Finance, FinTech, Biopharma, Internet, E-Commerce. The organization boasts a portfolio of 4 investments, with an average round size of $79.0M and 2 successful exits. Their recent investments include Countable, Global Catalyst Partners, Canaan Partners, Fernbrook Capital Management LLC, Billd. The highest investment round they participated in was $15.7B. Among their most notable exits are Countable and Global Catalyst Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
4
0
0
2
Investments
4
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 11, 2017 | Compass Therapeutics, Inc. | Biotechnology | null |
Jun 24, 2021 | Goat Group | E-Commerce | 195.0M |
Jul 13, 2021 | Billd | Financial Services | 30.0M |
Oct 20, 2021 | Countable | Software | 12.0M |
Exits
2
Funding Timeline
4
0
0
Funding Rounds
4
Ulysses Management has raised 4 rounds. Their latest funding was raised on Oct 20, 2021 from a Series A - Countable round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 11, 2017 | Series A - Compass Therapeutics, Inc. | - | 0 | - |
Jun 24, 2021 | Series F - Goat Group | - | 195.0M | - |
Jul 13, 2021 | Series B - Billd | - | 30.0M | - |
Oct 20, 2021 | Series A - Countable | - | 12.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.